Skip to main content
. 2023 Oct 31;14:1167860. doi: 10.3389/fpsyg.2023.1167860

Table 1.

Study schedule.

Study period
Enrolment Randomization Intervention (8 weekly sessions) Post (8 weeks) Follow-up (3 months)
TIMEPOINT T-1 T0 T1 T2
Enrolment:
Eligibility screen X
Informed consent X
Randomization X
Interventions:
Treatment As Usual (TAU) X X X X X
MCT-Silver X
Assessments:
Baseline
X
Post-intevention X
Follow up X